FDA

FDA blocks new clinical trials that ship cells from US to China

The action affects trials that ship living cells from the U.S. to “China and other hostile countries for genetic engineering and subsequent infusion."

Nick Paul Taylor Jun 20, 2025 10:30am

Industry disappointed as FDA reportedly puts Verdun on leave

Jun 20, 2025 1:53am

FDA 'on track' to meet all PDUFA dates, Marty Makary says

Jun 18, 2025 4:00am

FDA debuts priority review voucher with 2-month timeline goal

Jun 17, 2025 11:59am

Dexcom replaces handheld CGM receivers after missed audio alerts

Jun 17, 2025 10:40am

FDA slaps clinical hold on multiple Gilead HIV trials

Jun 10, 2025 10:48am